Hustinx, Roland ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de médecine nucléaire et imagerie onco ; UEMS Section Nuclear Medicine
Language :
English
Title :
Ausbildung in Nuklearmedizin und Zukunftsperspektiven.
Carrio I. Essler M. Freudenberg L. S. et al. COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty based on a report of Prof. Dr. Ignasi Carrio. Nuklearmedizin: 2020; 59 405 408
Wahl R. L. Chareonthaitawee P. Clarke B. et al. Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy. J Nucl Med: 2021; 62 01 6 14
American Cancer Society Cancer Facts and Figures 2020. Atlanta, Ga American Cancer Society: 2020
Neumaier F. Zlatopolskiy B. D. Neumaier B. Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics. Pharmaceutics: 2020; 12 12 1247 10.3390/pharmaceutics12121247
Lütje S. Marinova M. Kütting D. et al. Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19. Nuklearmedizin: 2020; 59 03 276 280
Du Y. Carrio I. De Vincentis G. et al. Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging: 2017; 44 10 1671 1678
Wang L. F. Lin L. Wang M. J. et al. The therapeutic efficacy of 177Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis. Medicine (Baltimore): 2020; 99 10 e19304
Prigent A. Hustinx R. Costa D. C. Nuclear medicine training in the European Union: 2015 update. Eur J Nucl Med Mol Imaging: 2016; 43 583 596
Varetto T. Costa D. C. Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients' rights in cross-border healthcare and professional qualifications. Eur J Nucl Med Mol Imaging: 2014; 41 2169 2173